Literature DB >> 10875849

Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH.

C H de Koning1, C Popp-Snijders, J Schoemaker, C B Lambalk.   

Abstract

Imminent ovarian failure (IOF) in women is characterized by regular menstrual cycles and elevated early follicular phase FSH. This study explored underlying neuroendocrine causes of elevated FSH concentrations on day 3 of the menstrual cycle. The characteristics of episodic secretion of FSH and LH, the pituitary response to gonadotrophin-releasing hormone (GnRH), plasma oestradiol, and dimeric inhibin A and inhibin B on day 3 were compared in 13 women with elevated FSH concentrations (>10 IU/l) and 16 controls. FSH amplitudes were higher in the IOF group than in the controls (P < 0. 0001). The FSH pulse frequency did not differ between groups. The FSH response to GnRH was higher in the IOF patients than in the controls (P < 0.0001). Mean LH, LH amplitude and LH response to GnRH were higher in the IOF group, but LH pulse frequency did not differ between the groups. Concentrations of inhibin A and inhibin B were lower in the IOF group, while oestradiol showed no differences. We concluded that in women with IOF, the pituitary is more sensitive to GnRH. This leads to higher FSH and LH pulse amplitudes which underlie the elevated FSH concentrations in the early follicular phase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875849     DOI: 10.1093/humrep/15.7.1452

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs.

Authors:  Dimitris Loutradis; Eleni Patsoula; Vassilis Minas; Giorgos A Koussidis; Aristeidis Antsaklis; Stylianos Michalas; Antonis Makrigiannakis
Journal:  J Assist Reprod Genet       Date:  2006-05-19       Impact factor: 3.412

2.  Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women.

Authors:  Hengxi Chen; Li Xiao; Jinke Li; Lin Cui; Wei Huang
Journal:  Cochrane Database Syst Rev       Date:  2019-03-03

3.  Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective in Women with Impending Ovarian Failure and Diminished Ovarian Reserve.

Authors:  Chao-Chin Hsu; Isabel Hsu; Li-Hsuan Lee; Yuan-Shuo Hsueh; Chih-Ying Lin; Hui Hua Chang
Journal:  Biomedicines       Date:  2022-06-03

4.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying MicroRNA-29a Improves Ovarian Function of Mice with Primary Ovarian Insufficiency by Targeting HMG-Box Transcription Factor/Wnt/β-Catenin Signaling.

Authors:  Tian Gao; Yi Cao; Min Hu; Ying Du
Journal:  Dis Markers       Date:  2022-07-02       Impact factor: 3.464

5.  Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.

Authors:  Qiuju Chen; Yun Wang; Lihua Sun; Shaozhen Zhang; Weiran Chai; Qingqing Hong; Hui Long; Li Wang; Qifeng Lyu; Yanping Kuang
Journal:  Reprod Biol Endocrinol       Date:  2017-09-05       Impact factor: 5.211

6.  Live Birth Rate in Patients With Premature Ovarian Insufficiency During Long-Term Follow-Up Under Hormone Replacement With or Without Ovarian Stimulation.

Authors:  Bunpei Ishizuka; Masataka Furuya; Machiko Kimura; Eri Kamioka; Kazuhiro Kawamura
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-17       Impact factor: 5.555

7.  2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-Glucoside improves female ovarian aging.

Authors:  Hung-Yun Lin; Yung-Ning Yang; Yi-Fong Chen; Tung-Yung Huang; Dana R Crawford; Hui-Yu Chuang; Yu-Tang Chin; Hung-Ru Chu; Zi-Lin Li; Ya-Jung Shih; Yi-Ru Chen; Yu-Chen S H Yang; Yih Ho; Paul J Davis; Jacqueline Whang-Peng; Kuan Wang
Journal:  Front Cell Dev Biol       Date:  2022-08-30

8.  Characterization of micro-RNA in women with different ovarian reserve.

Authors:  Masood Abu-Halima; Lea Simone Becker; Basim M Ayesh; Simona Lucia Baus; Amer Hamza; Ulrike Fischer; Mohamad Hammadeh; Andreas Keller; Eckart Meese
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.